Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer.
about
Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cellsGonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent mannerActivation of alternate prosurvival pathways accounts for acquired sunitinib resistance in U87MG glioma xenografts.Accumulation of Palmitoylcarnitine and Its Effect on Pro-Inflammatory Pathways and Calcium Influx in Prostate Cancer.Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.The Effect of Tumor Microenvironment on Autophagy and Sensitivity to Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma.The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy.A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice.The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma.RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivation.
P2860
Q28484299-73D831DD-0D43-4027-9D2F-B82523095598Q28537723-D164FB61-FB3D-4038-95A4-12E3760B6F86Q36335477-A9FC87BC-1130-4997-9B65-A4628A3A84ACQ37200709-C590BCE9-9306-4D4F-AB10-E9D85C007644Q37613495-73A64DBA-B33E-44FA-A63A-0F8D45CA62EFQ40185493-B664CDD6-B8CE-456D-AD30-600A8121577EQ41775545-42800BB9-3F5F-445D-A7CC-21D4C334510EQ44456046-9300DBF3-1808-4D46-81E7-1B69B0543EC4Q51711371-32867ABC-A322-4B35-8AB6-BB7C90537961Q52728099-91B87AC4-8D19-471B-A631-7FFDA2A21752Q54978480-9B05DAAF-8EA6-4B21-AACC-E01A492BDCFC
P2860
Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interleukin-6: a potential bio ...... ion-resistant prostate cancer.
@ast
Interleukin-6: a potential bio ...... ion-resistant prostate cancer.
@en
type
label
Interleukin-6: a potential bio ...... ion-resistant prostate cancer.
@ast
Interleukin-6: a potential bio ...... ion-resistant prostate cancer.
@en
prefLabel
Interleukin-6: a potential bio ...... ion-resistant prostate cancer.
@ast
Interleukin-6: a potential bio ...... ion-resistant prostate cancer.
@en
P2093
P2860
P1433
P1476
Interleukin-6: a potential bio ...... ion-resistant prostate cancer.
@en
P2093
Alexander Kutikov
Daniel J Canter
Jay Simhan
Konstantin Golovine
Mohit Sirohi
Peter Makhov
Robert G Uzzo
Ryan Street
Vladimir M Kolenko
P2860
P304
P356
10.1016/J.UROLOGY.2011.07.1384
P407
P577
2011-10-01T00:00:00Z